Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Guangzhou Pharmaceutical Co Ltd Updates Merger with Guangzhou Baiyunshan Pharmaceutical Co Ltd


Thursday, 25 Apr 2013 08:00pm EDT 

Guangzhou Pharmaceutical Company Limited announced that its share swap with Guangzhou Baiyunshan Pharmaceutical Co Ltd (Baiyunshan) will be implemented on April 26, 2013 and Baiyunshan will be delisted from Shenzhen Stock Exchange on the same day. The Company will issue 445,601,005 A shares of common stock with par value of RMB 1 per share at RMB 12.20 per share, to all shareholders of Baiyunshan, recorded on April 26, 2013, with one new shares to be exchanged for 0.95 existing share of Baiyunshan, to acquire a 100% stake in Baiyunshan. After that, Baiyunshan will be dissolved. 

Company Quote